Experience life to the fullest with Dr Reddy's Lactic Acid Reducer Antibiotics. This powerful medicine, manufactured by a unique combination of Tetracycline and Lactic Acid Reducer, has the ability to replenish the body’s natural pH levels, giving patients the confidence to tackle bacterial infections at their most challenging time. This powerful antibiotic uses the same active ingredient, Lactic Acid, as Tetracycline but offers a unique combination of Tetracycline and Lactic Acid to help restore healthy bacteria.
This powerful antibiotic can alleviate a variety of bacterial infections, including ear infections, sinus infections, urinary tract infections, and skin and soft tissue infections. It works by inhibiting bacterial protein synthesis, thereby reducing the production of essential nutrients needed for healthy cells. This medication is available in doses of 500mg and 2g to be taken once daily, which are ideal for adults and children for whom it is not suitable. The dosage of Lactic Acid depends on the type and severity of the infection and should be taken according to the doctor’s recommendations. The antibiotic is taken orally with water, typically three times a day, for several days.
A great antibiotic for treating infections, this product has been clinically proven to effectively combat a wide range of bacterial infections. It works by targeting and eliminating harmful bacteria that are present in the body and causing symptoms such as stomach upset, diarrhea, and abdominal pain. By blocking the production of essential amino acids needed for healthy bacteria and the synthesis of proteins essential for growth and survival, this medication makes the treatment of infections more difficult. It helps to restore the balance of good bacteria in the body and reduce the frequency and severity of infections.
The active ingredient of Lactic Acid Reducer Antibiotics, Tetracycline, works by inhibiting bacterial protein synthesis, thereby reducing the production of essential amino acids needed for healthy bacteria. It inhibits the growth and reproduction of bacteria and stops their spread.
The medicine is a powerful tool for individuals suffering from bacterial infections. It helps to alleviate symptoms and eliminate the bacteria responsible for the infection. The antibiotic works by inhibiting bacterial protein synthesis, thereby decreasing the production of essential amino acids needed for healthy bacteria. It is an antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, urinary tract infections, and respiratory tract infections.
A great antibiotic for treating bacterial infections, this product has been clinically proven to effectively combat a wide range of bacterial infections. By blocking the production of essential amino acids needed for healthy bacteria and the synthesis of proteins essential for growth and survival, this medication helps to restore the balance of good bacteria in the body. It works by eliminating harmful bacteria and helping to reduce the frequency and severity of infections.
The active ingredient of Lactic Acid Reducer Antibiotics, Lactobacillus, works by preventing bacterial cell death and enhancing the production of essential amino acids needed for healthy bacteria. It works by inhibiting bacterial protein synthesis, which prevents the bacteria from multiplying. Lactobacillus helps to prevent the growth and spread of harmful bacteria in the body. Lactobacillus is a naturally occurring derivative of the antibiotic lactic acid, which belongs to the tetracycline class of antibiotics. It works by inhibiting the growth and reproduction of bacteria, preventing the spread of infections and providing relief from symptoms caused by the bacteria.
It works by inhibiting the growth and reproduction of bacteria, preventing the spreading of infections and providing relief from symptoms caused by the bacteria.
Save16%
Original price$ 319.00
Current price$ 269.00
SKU23155-0767-01
Medical Professional License Required to Unlock Account(Note: We don’t Fill Personal Prescriptions)How to Order:
✔Send an email request to: [email protected]
You will receive instructions on how to create an account along with Rx Ordering Details.
Tetracycline HCl Capsules USP 500 mg is an antibiotic medication used to treat a variety of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections. It belongs to a class of antibiotics called tetracyclines, which work by preventing the growth and spread of bacteria. This medication should only be used to treat bacterial infections and will not work for viral infections such as the common cold or flu. Tetracycline HCl Capsules USP 500 mg is a prescription medication used to treat bacterial infections, including those involving the skin, respiratory tract, urinary tract, and digestive system. It can also be used to treat certain sexually transmitted infections and other conditions as determined by a doctor. The capsules are usually taken orally and the dosage and length of treatment will depend on the specific infection being treated. It is important to finish the full course of treatment prescribed by the doctor, even if the symptoms improve. It is important to take Tetracycline HCl Capsules USP 500 mg on an empty stomach (at least one hour before or two hours after meals) with a full glass of water. This medication should not be taken with dairy products, antacids, or iron supplements, as they can decrease the effectiveness of the medication. If the medication is being used to treat an infection, symptoms should start to improve within a few days. However, it is important to continue taking the medication for the prescribed length of time to ensure that the infection is fully treated and to prevent bacteria from becoming resistant to the antibiotic. If a dose is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be resumed. Tetracycline HCl Capsules USP 50 mg may interact with other medications and supplements, so it is important to inform the doctor of any other medications being taken. It is also important to let the doctor know if there are any allergies to tetracycline or other antibiotics. Possible side effects of Tetracycline HCl Capsules USP 500 mg include nausea, vomiting, stomach upset, diarrhea, loss of appetite, and headache. If these side effects are severe or persistent, it is important to inform the doctor. If any serious side effects occur, such as difficulty breathing, yellowing of the skin or eyes, or symptoms of a severe allergic reaction, seek medical attention immediately. It is important to complete the full prescribed course of treatment for Tetracycline HCl Capsules USP 500 mg, even if symptoms improve, in order to fully eradicate the infection and prevent bacteria from becoming resistant to the medication.
Read More AboutTetracycline HCl Capsules USP 500 mgBy ordering Tetracycline HCl Capsules USP 500 mg, you are able to order Tetracycline HCl Capsules USP from multiple international online pharmacies to ensure you are purchasing a quality medication. To improve your online shopping experience, Tetracycline HCl Capsules USP can be used to help treat various bacterial infections, including respiratory tract infections, skin infections, urinary tract infections, and certain gastrointestinal infections. It is important to complete the prescribed course of treatment for the Tetracycline HCl Capsules USP 500 mg. It is usually safe to take Tetracycline HCl Capsules USP 500 mg as directed by the doctor. However, if you experience any severe side effects or allergic reactions, it is important to seek medical attention.
How to TakeThe dosage of Tetracycline HCl Capsules USP 500 mg is based on the number of bacterial infections being treated, as well as other potential factors.
The mechanism by which Tetracycline inhibits the growth and proliferation of mammalian cells is not known. However, it has been shown to have anti-cancer activity. The ability of Tetracycline to inhibit the proliferation of human and murine cancer cells suggests that Tetracycline might have a role in modulating cell cycle progression and apoptosis. This hypothesis is supported by observations that the inhibition of cell division by Tetracycline can alter the apoptotic and necrotic processes in mammalian cells. We have developed a new assay that measures the number of apoptotic cells in a fixed cell culture and that detects cell cycle arrest and apoptosis.
Citation:Ginzer T, Mascone T, De La Torre P, De Santi M, et al. (2013) Tetracycline inhibits the growth and proliferation of mammalian cells by inhibiting caspase-3 and -7. PLoS ONE 12(7): e007909. https://doi.org/10.1371/journal.pone.007909
Editor:Mikael L. Leopold, McGill University, Canada
Received:March 4, 2013;Accepted:July 23, 2013;Published:August 21, 2013
Copyright:© 2013 Ginzer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding:This work was supported by grants from the American Cancer Society and National Institutes of Health (R01 CA143379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests:The authors have declared that no competing interests exist.
The role of Tetracycline in bacterial infections is complicated. The primary drug target isE. coli() andShigellaare implicated in most bacterial infections (, ). Tetracycline has been shown to inhibit the growth and proliferation ofcell lines, but this has not been fully elucidated (, ). In this report we demonstrate that the ability ofto produce Tetracycline (a drug used to treat rheumatic diseases) is dependent on the expression of the cell-permeable transactivator Tetracycline-dependent GFP (gfp).
In a previous study, we showed that the gfp-expressingcell lines (J01-11, J01-13, J01-14, J01-15) express a low basal level of the GFP transactivator. We therefore investigated the effects ofon the intracellular GFP concentrations in J01-11 and J01-13 cells. Using these cell lines, we found that the intracellular GFP concentration was much higher in J01-11 and J01-13 cells compared to J01-13 cells (,, ). This suggests that, as Tetracycline inhibits the growth and proliferation of these cell lines, the intracellular GFP concentration in J01-11 and J01-13 cells can be reduced. We also found that the intracellular GFP concentration was higher in J01-11 and J01-13 cells compared to J01-13 cells. These data suggest that Tetracycline inhibits the growth and proliferation ofcell lines.
A recent study demonstrated that the intracellular GFP concentration was increased byin a time- and dose-dependent manner (, ). This suggests that the ability ofto increase intracellular GFP concentrations may depend on the expression of the cell-permeable transactivator. In this study, we tested the effect ofon the intracellular GFP concentration in J01-13 cells and determined whether the intracellular GFP concentration was decreased byin a time- and dose-dependent manner.
Molecular Biology
Objective:To investigate the response of the human promoters to Tetracycline-inducible expression systems (TICs) and to the role of the promoters in the production of cell-permeable tetracycline-controlled genes in vitro. In order to achieve our goal, we designed TICs for transgene expression in human stem cells and characterized the effects of the TIC on gene expression. TIC-dependent gene expression is mediated by the tetracycline-controlled gene promoters. In order to study the role of these promoters in cell-specific gene expression, we tested several TIC systems that are currently used to study the function of the human promoters.
Methods:We constructed a library of tetracycline responsive promoters and examined the effects of TICs on the expression of two cell-permeable tetracycline-controlled genes. We then performed an inducible gene expression system in transgenic mice and transgenic mice that contain a tetracycline-responsive gene promoter. We then examined the effects of TIC-dependent gene expression on the expression of two cell-permeable tetracycline-controlled genes in vivo. All these studies are reported in the paper.
Results:To study the effects of the TIC-inducible expression system, we constructed a library of TIC-inducible promoter elements in a transgenic mouse model, which we used to study the role of the TIC-inducible promoter system. We then performed inducible gene expression in a transgenic mouse model and transgenic mouse that contain a tetracycline-responsive gene promoter. These studies are reported in the paper.
Conclusion:We constructed a library of tetracycline-inducible promoters in a transgenic mouse model, which we used to study the role of the TIC-inducible promoter system. We then performed an inducible gene expression system in a transgenic mouse model and transgenic mouse that contain a tetracycline-responsive gene promoter.
References:1. L. K. P. M. et al. TicT-Inducible Intersym. 2008;13(6):11-16.
2. (2013)Cell Mol Mol Biol. 5:3-9.3. A. (2017)Proc Natl Acad Sci USA4:14-16.Published by:
Stade de France Pharmacy